Vstm3 is a member of the CD28 family and an important modulator of T‐cell function

Members of the CD28 family play important roles in regulating T‐cell functions and share a common gene structure profile. We have identified VSTM3 as a protein whose gene structure matches that of the other CD28 family members. This protein (also known as TIGIT and WUCAM) has been previously shown to affect immune responses and is expressed on NK cells, activated and memory T cells, and Tregs. The nectin‐family proteins CD155 and CD112 serve as counter‐structures for VSTM3, and CD155 and CD112 also bind to the activating receptor CD226 on T cells and NK cells. Hence, this group of interacting proteins forms a network of molecules similar to the well‐characterized CD28–CTLA‐4–CD80–CD86 network. In the same way that soluble CTLA‐4 can be used to block T‐cell responses, we show that soluble Vstm3 attenuates T‐cell responses in vitro and in vivo. Moreover, animals deficient in Vstm3 are more sensitive to autoimmune challenges indicating that this new member of the CD28 family is an important regulator of T‐cell responses.

[1]  J. Anaya,et al.  Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. , 2010, Rheumatology.

[2]  N. Stanietsky,et al.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[3]  Eric Vivier,et al.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans , 2009, The Journal of experimental medicine.

[4]  B. Harder,et al.  Recombinant Soluble Human FcγR1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis1 , 2009, The Journal of Immunology.

[5]  L. Maier,et al.  Autoimmunity risk alleles in costimulation pathways , 2009, Immunological reviews.

[6]  M. Colonna,et al.  A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC , 2009, European journal of immunology.

[7]  T. Yasui,et al.  Accelerated tumor growth in mice deficient in DNAM-1 receptor , 2008, The Journal of experimental medicine.

[8]  M. Colonna,et al.  DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors , 2008, The Journal of experimental medicine.

[9]  E. Kremmer,et al.  The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1. , 2007, Biochemical and biophysical research communications.

[10]  R. Parry,et al.  Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation. , 2007, Trends in immunology.

[11]  H. Ljunggren,et al.  DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. , 2007, Cancer research.

[12]  S. Quezada,et al.  Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. , 2006, Current opinion in immunology.

[13]  S. Honda,et al.  Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. , 2006, Blood.

[14]  K. Murphy,et al.  Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts1 , 2005, The Journal of Immunology.

[15]  G. Freeman,et al.  CD226 Is Specifically Expressed on the Surface of Th1 Cells and Regulates Their Expansion and Effector Functions1 , 2005, The Journal of Immunology.

[16]  Darrell Conklin,et al.  Gene finding for the helical cytokines , 2005, Bioinform..

[17]  S. Honda,et al.  Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. , 2005, Biochemical and biophysical research communications.

[18]  A. Sharpe,et al.  The B7/CD28 costimulatory family in autoimmunity , 2005, Immunological reviews.

[19]  E. Lanino,et al.  Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). , 2005, Blood.

[20]  L. Moretta,et al.  PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. , 2005, Molecular immunology.

[21]  D. Louis,et al.  CD155/PVR plays a key role in cell motility during tumor cell invasion and migration , 2004, BMC Cancer.

[22]  K. Irie,et al.  Involvement of heterophilic trans‐interaction of Necl‐5/Tage4/PVR/CD155 with nectin‐3 in formation of nectin‐ and cadherin‐based adherens junctions , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  C. June,et al.  SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 , 2004, The Journal of Immunology.

[24]  D. Bigner,et al.  Poliovirus receptor CD155-targeted oncolysis of glioma. , 2004, Neuro-oncology.

[25]  E. Devilard,et al.  DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions , 2004, The Journal of experimental medicine.

[26]  Lewis L Lanier,et al.  Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). , 2004, International immunology.

[27]  M. Colonna,et al.  Cutting Edge: CD96 (Tactile) Promotes NK Cell-Target Cell Adhesion by Interacting with the Poliovirus Receptor (CD155) , 2004, The Journal of Immunology.

[28]  R. Förster,et al.  Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. , 2003, Biochemical and biophysical research communications.

[29]  L. Moretta,et al.  Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule , 2003, The Journal of experimental medicine.

[30]  J. Allison,et al.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.

[31]  H. Lassmann,et al.  A comparative analysis of B cell‐mediated myelin oligodendrocyte glycoprotein‐experimental autoimmune encephalomyelitis pathogenesis in B cell‐deficient mice reveals an effect on demyelination , 2002, European journal of immunology.

[32]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[33]  T. Okazaki,et al.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Denis,et al.  Overexpression of the CD155 gene in human colorectal carcinoma , 2001, Gut.

[35]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[36]  R. Perlmutter,et al.  Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. , 1999, Immunity.

[37]  R. Karr,et al.  CTLA-4-Fc treatment of ongoing EAE improves recovery, but has no effect upon relapse rate. Implications for the mechanisms involved in disease perpetuation , 1999, Journal of Neuroimmunology.

[38]  M. Feldmann,et al.  Prevention and amelioration of collagen‐induced arthritis by blockade of the CD28 co‐stimulatory pathway: requirement for both B7‐1 and B7‐2 , 1996, European journal of immunology.

[39]  M. W. Flye,et al.  Inhibition by CTLA4Ig of experimental allergic encephalomyelitis. , 1996, Journal of immunology.

[40]  F J Grant,et al.  Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.

[41]  E. Wimmer,et al.  Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily , 1989, Cell.

[42]  H. Clark,et al.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells , 2009, Nature Immunology.

[43]  J. Haines,et al.  The expanding genetic overlap between multiple sclerosis and type I diabetes , 2009, Genes and Immunity.

[44]  J. Todd,et al.  CD226 Gly307Ser association with multiple autoimmune diseases , 2009, Genes and Immunity.

[45]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[46]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[47]  G. Morahan,et al.  T cell tolerance and autoimmunity. , 1997, Ciba Foundation symposium.